相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetics of ankylosing spondylitis
Philip C. Robinson et al.
MOLECULAR IMMUNOLOGY (2014)
Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification
Walter P. Maksymowych et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Viewpoint Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis
Philip Cameron Robinson et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
I-H Song et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48
I-H Song et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Clinical and Imaging Efficacy of Infliximab in HLA-B27-Positive Patients With Magnetic Resonance Imaging-Determined Early Sacroiliitis
Nick Barkham et al.
ARTHRITIS AND RHEUMATISM (2009)
Inflammatory Lesions of the Spine on Magnetic Resonance Imaging Predict the Development of New Syndesmophytes in Ankylosing Spondylitis
Walter P. Maksymowych et al.
ARTHRITIS AND RHEUMATISM (2009)
Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Robert D. Inman et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
JC Davis et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
X Baraliakos et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
J Brandt et al.
ARTHRITIS AND RHEUMATISM (2003)
分享论文
